Dr Patricia Illing is a Group Leader at the Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology at Monash University, focussed on understanding peptide and small molecule presentation to T cells by Human Leukocyte Antigen (HLA), and HLA-like, molecules in the context of infection, drug-hypersensitivity, and cancer. Dr Illing undertook her PhD at the University of Melbourne in laboratory of Professor James McCluskey, before commencing an NH&MRC Peter Doherty Early Career Fellowship in 2014 in the laboratory of Professor Tony Purcell at Monash University. She was subsequently appointed as a Group Leader in 2021. Her work integrates proteomics, immunopeptidomics and functional immunology to understand the interplay between genetic factors (HLA polymorphisms, antigen processing machinery) and environmental factors (therapeutic drugs, infection) in peptide and small molecule presentation by HLA, and HLA-like, molecules.